Recent trends in hepatitis B virus infection in the general Korean population

被引:57
作者
Kim, Hyuck
Shin, A. Ri
Chung, Hoe Hoon
Kim, Min Kyoung
Lee, Ji Sung
Shim, Jae-Jun
Kim, Byung-Ho
机构
[1] Department of Internal Medicine, Kyung Hee University Medical Center, Seoul
[2] Department of Biostatistics, Korea University College of Medicine, Seoul
关键词
VACCINATION;
D O I
10.3904/kjim.2013.28.4.413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Hepatitis B virus (HBV) is the major cause of chronic liver disease in Korea, but viral prevalence has decreased because of hepatitis B vaccination programs. In this study, we investigated longitudinal changes in HBV in fection in the general Korean population. Methods: HBV surface antigen (hepatitis B surface antigen, HBsAg) seropositivity was assessed from the Korea National Health and Nutrition Examination Survey (I to V). In total, 50,140 subjects were tested for serum HBsAg positivity over a period of 12 years (1998 to 2010). Results: The prevalence of HBsAg seropositivity decreased over the study period. The rates of HBsAg carriers were 4.61% in 1998, 4.60% in 2001, 3.69% in 2005, 3.01% in 2008, and 2.98% in 2010 (p < 0.0001). The reduction in HBV infection rates was more prominent in younger age groups. Among teenagers (10 to 19 years), the percentage of HBsAg carriers decreased from 2.2% in 1998 to 0.12% in 2010 (p < 0.0001). Among those aged io to 39 years, the percentage of HBV infection decreased from 4.72% in 1998 to 2.29% in 2010 (p < 0.0001). However, no decreasing trend in HBsAg positivity was observed among those aged 50 or older (p > 0.05). Neither gender nor socioeconomic status were associated with the decreased prevalence of HBsAg carriers. Conclusions: HBV infection has decreased in the Korean population since the advent of vaccination programs. However, the decrease is limited to the younger population, and viral persistence remains in the middle-aged and older population.
引用
收藏
页码:413 / 419
页数:7
相关论文
共 21 条
[1]  
Ahn YO, 2010, KOREAN J HEPATOL S, V16, pS23
[2]  
[Anonymous], 2009, Wkly Epidemiol Rec, V84, P405
[3]  
[Anonymous], J KOREAN PEDIAT SOC
[4]  
BEASLEY RP, 1983, LANCET, V2, P1099
[5]  
Chae Hee Bok, 2009, Korean J Hepatol, V15 Suppl 6, pS13, DOI 10.3350/kjhep.2009.15.S6.S13
[6]   Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls [J].
Chang, MH ;
Shau, WY ;
Chen, CJ ;
Wu, TC ;
Kong, MS ;
Liang, DC ;
Hsu, HM ;
Chen, HL ;
Hsu, HY ;
Chen, DS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (23) :3040-3042
[7]  
Han BS, 1989, KOREAN J EPIDEMIOL, V11, P215
[8]  
Hwang EW., 2011, N Am J Med Sci, V4, P7, DOI DOI 10.7156/V4I1P007
[9]  
Hwang Sang Hyun, 2006, Korean J Lab Med, V26, P436, DOI 10.3343/kjlm.2006.26.6.436
[10]  
Jang KM, 1983, KOREAN J INTERN MED, V26, P1331